Alex Mompoint, MD

Article Type

Article

Changed

Fri, 11/02/2018 - 09:10

Display Headline

Vertebral compression fractures: Manage aggressively to prevent sequelae

Author(s)

Daniel J. Mazanec, MD

Vinod K. Podichetty, MD

Alex Mompoint, MD

Amarish Potnis, MD

Article PDF

content_70_147.pdf

Author and Disclosure Information

Daniel J. Mazanec, MD
Director, Spine Center, Department of Physical Medicine and Rehabilitation, The Cleveland Clinic

Vinod K. Podichetty, MD
Coordinator, Research Studies, Spine Center, Department of Physical Medicine and Rehabilitation, The Cleveland Clinic

Alex Mompoint, MD
Spine Center, Department of Physical Medicine and Rehabilitation, The Cleveland Clinic

Amarish Potnis, MD
Telemark Physical Medicine, Greenville, PA

Address: Daniel J. Mazanec, MD, Director, Spine Center, Rheumatologic & Immunologic Disease, C21, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: mazaned@ccf.org

This paper discusses therapies that are not approved by the US Food and Drug Administration for the use under discussion.

Issue

Cleveland Clinic Journal of Medicine - 70(2)

Publications

Cleveland Clinic Journal of Medicine

Topics

Pain

Rheumatology

Page Number

147-156

Read more about Vertebral compression fractures: Manage aggressively to prevent sequelae

Sections

Reviews

Author(s)

Daniel J. Mazanec, MD

Vinod K. Podichetty, MD

Alex Mompoint, MD

Amarish Potnis, MD

Author(s)

Daniel J. Mazanec, MD

Vinod K. Podichetty, MD

Alex Mompoint, MD

Amarish Potnis, MD

Author and Disclosure Information

Daniel J. Mazanec, MD
Director, Spine Center, Department of Physical Medicine and Rehabilitation, The Cleveland Clinic

Vinod K. Podichetty, MD
Coordinator, Research Studies, Spine Center, Department of Physical Medicine and Rehabilitation, The Cleveland Clinic

Alex Mompoint, MD
Spine Center, Department of Physical Medicine and Rehabilitation, The Cleveland Clinic

Amarish Potnis, MD
Telemark Physical Medicine, Greenville, PA

Address: Daniel J. Mazanec, MD, Director, Spine Center, Rheumatologic & Immunologic Disease, C21, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: mazaned@ccf.org

This paper discusses therapies that are not approved by the US Food and Drug Administration for the use under discussion.

Author and Disclosure Information

Daniel J. Mazanec, MD
Director, Spine Center, Department of Physical Medicine and Rehabilitation, The Cleveland Clinic

Vinod K. Podichetty, MD
Coordinator, Research Studies, Spine Center, Department of Physical Medicine and Rehabilitation, The Cleveland Clinic

Alex Mompoint, MD
Spine Center, Department of Physical Medicine and Rehabilitation, The Cleveland Clinic

Amarish Potnis, MD
Telemark Physical Medicine, Greenville, PA

Address: Daniel J. Mazanec, MD, Director, Spine Center, Rheumatologic & Immunologic Disease, C21, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: mazaned@ccf.org

This paper discusses therapies that are not approved by the US Food and Drug Administration for the use under discussion.

Article PDF

content_70_147.pdf

Article PDF

content_70_147.pdf

Issue

Cleveland Clinic Journal of Medicine - 70(2)

Issue

Cleveland Clinic Journal of Medicine - 70(2)

Page Number

147-156

Page Number